1. Antimetabolites;Allegra,1987
2. Cytosine arabinoside (NSC-63878)-clinical brochure;Livingston;Cancer Chemother. Rep.,1968
3. Toxicity studies in mice treated with 1-β-D-arabinofuranosylcytosine (ara-C);Leach;Cancer Res.,1969
4. Effect of cytosine arabinoside on differentiation of normal human bone marrow cells;Nagler;Exp. Hematol.,1986
5. Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion;Donehower;Cancer Treat. Rep.,1986